[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359728-105":59,"doc-detail-359728-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","indocyanine-green-fluorescence-for-intraoperative-detection-of-liver-tumours-in-minimally-invasive-surgery-protocol-for-the-livergreen-phase-iv-multicentre-clinical-trial","Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery - protocol for the LIVERGREEN phase IV multicentre clinical trial","","A prospective, multicentre phase IV clinical trial evaluates how preoperative indocyanine green (ICG) influences intraoperative detection of liver tumours during minimally invasive surgery and supports development of an artificial intelligence model. Eligible patients receive intravenous ICG 24 hours before operation, with intraoperative ultrasound, ICG mapping and photographic documentation. Standard SPIRIT adherence guides conduct. Participants are followed for 90 days to measure tumour progression, morbidity and mortality, and reference confirmation uses histopathology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/indocyanine-green-fluorescence-for-intraoperative-detection-of-liver-tumours-in-minimally-invasive-surgery-protocol-for-the-livergreen-phase-iv-multicentre-clinical-trial/359728/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/indocyanine-green-fluorescence-for-intraoperative-detection-of-liver-tumours-in-minimally-invasive-surgery-protocol-for-the-livergreen-phase-iv-multicentre-clinical-trial/359728.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the LIVERGREEN phase IV multicentre trial?","Question",{"text":112,"@type":113},"To assess the impact of preoperative ICG on intraoperative tumour detection in minimally invasive liver surgery and to develop a machine-learning algorithm using ICG fluorescence and photographic images.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is ICG administered and used during surgery?",{"text":117,"@type":113},"ICG is given intravenously 24 hours before surgery, and intraoperative procedures include IOUS, ICG mapping, and photographic documentation for lesion identification.",{"name":119,"@type":110,"acceptedAnswer":120},"What outcomes are assessed during follow-up?",{"text":121,"@type":113},"Patients are followed for 90 days to evaluate tumour progression, morbidity and mortality, with histopathological examination of resected specimens used as the reference standard for lesion confirmation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359728,1790472353,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Open access Protocol  \n Indocyanine green fluorescence for  \nintraoperative detection of liver tumoursin minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial  \nMartín Huerta  ,1,2 Santiago Lopez-Ben,3 Laura Lladó,4,5  \nSantiago Sánchez-Cabús,2,6 Kristel Mils,4,5 Víctor Molina,2,6 Cristina Dopazo,1,2 Laura Vidal,1,2 Mar Dalmau,1,2 Mireia Caralt,1,2 Nuria Rosón,2,7 Xavier Merino,2,7 David Armario,2,7 María Teresa Salcedo,2,8 Gianluca Pellino,2,9  \nGonzalo Sapisochin,1,2 Concepción Gómez-Gavara,1,2 LIVERGREEN Collaborative Group10  \nTo cite: Huerta M, Lopez-Ben S, Lladó L, et al. Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery:  \nprotocol for the LIVERGREEN phase IV multicentre  \nclinical trial. BMJ Open 2026;16:e118275 . doi:10 . 1136/ bmjopen-2026-118275  \n► Prepublication history and additional supplemental material for this paper are available online. To view these files, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[bmjopen-2026-118275](bmjopen-2026-118275)) .  \nReceived 12 February 2026 Accepted 25 March 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Concepción Gómez-Gavara; imgoga@hotmail.com and Dr Gonzalo Sapisochin;  \ngonzalo.sapisochin@vallhebron. cat  \nABSTRACT  \nIntroduction Liver tumours are a leading cause of global morbidity and mortality. Current diagnostic tools, including computed tomography (CT), magnetic resonance imaging (MRI) and intraoperative ultrasound (IOUS), have limitations in detecting liver neoplasms. Indocyanine green (ICG) has emerged as a promising tool for improving liver tumour detection. This study aims to assess the impact of preoperative ICG on intraoperative tumour detection in minimally invasive surgery and develop a machinelearning algorithm to enhance tumour detection using ICG fluorescence.  \nMethods and analysis This prospective, multicentre, phase IV clinical trial adheres to Standard Protocol Items:  \nRecommendations for Interventional Trials (SPIRIT) guidelines. Patients with liver tumours eligible for minimally invasive surgery and a preoperative imaging test will be included. ICG will be administered intravenously 24 hours before surgery. Intraoperative procedures  \nwill include IOUS, ICG mapping and photographic documentation. Patients will be followed for 90 days to assess tumour progression, morbidity and mortality. The photographic analysis will enable the development of an artificial intelligence algorithm using machine learning and neural networks to identify lesions based on ICG fluorescence. The estimated sample size is 173 patients and the trial is predicted to accrue in 3 years.  \nEthics and dissemination The trial will be conducted in accordance with the Declaration of Helsinki and the Spanish Agency of Medicines and Medical Devices (AEMPS) guidelines. Approved by the local institutional Ethics Committee and the AEMPS, the results will be shared with the scientific community through publications and conferences.  \nEudraCT number 2023–5 08 316-27-00.  \nTrial registration number NCT06398028 . Protocol version V.12, 18 March 2025  \nSTRENGTHS AND LIMITATIONS OF THIS STUDY   \n⇒ Prospective multicentre phase IV clinical trial including four tertiary hepatobiliary surgery centres.  \n⇒ Standardised protocol for Indocyanine green (ICG) administration (weight-adjusted dose given 24 hours preoperatively) and use of the same fluorescence imaging system across centres.  \n⇒ Systematic intraoperative lesion assessment combining preoperative imaging mapping, intraoperative ultrasound, ICG fluorescence mapping and photographic documentation.  \n⇒ Histopathological examination of resected specimens used as the reference standard for lesion confirm","cbCain2CjYNCqPrO","https://ap.wps.com/l/cbCain2CjYNCqPrO","pdf",547629,"English","# Abstract\n## Introduction\n## Methods and analysis\n## Ethics and dissemination\n# Strengths and limitations\n# Background\n# Methods and analysis\n## Objectives","[{\"question\":\"What is the purpose of the LIVERGREEN phase IV multicentre trial?\",\"answer\":\"To assess the impact of preoperative ICG on intraoperative tumour detection in minimally invasive liver surgery and to develop a machine-learning algorithm using ICG fluorescence and photographic images.\"},{\"question\":\"How is ICG administered and used during surgery?\",\"answer\":\"ICG is given intravenously 24 hours before surgery, and intraoperative procedures include IOUS, ICG mapping, and photographic documentation for lesion identification.\"},{\"question\":\"What outcomes are assessed during follow-up?\",\"answer\":\"Patients are followed for 90 days to evaluate tumour progression, morbidity and mortality, with histopathological examination of resected specimens used as the reference standard for lesion confirmation.\"}]","Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery - protocol for the LIVERGREEN phase IV multicentre clinical trial | PDF",1790137656,18,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23a22b411367be1852b88e76dc1aa150.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5934a2e94b46b947ba0194ef36bda74.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/291749c03ac4ead81249ac7884fd66db.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d4843dcc0c4c70d0444dd6682caf2865.webp",980,1306]